This book is a comprehensive and easy-to-read guide to pulmonary imaging. Medical Imaging is one of the cornerstones of modern medicine, and nowhere is this more apparent than pulmonary disease. We have come a long way from the days of chest radiography, though the chest radiograph still remains the single most common imaging test ordered worldwide. Pulmonary disease is now routinely evaluated with ultra-modern computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) scanners, while ultrasonography plays a limited role in critical care and pleural/chest wall diseases. Rapid advancements in the sub-specialty of chest imaging and an exponential increase in the knowledge of pulmonary disease have led to an increasing demand for a comprehensive yet easily digestible handbook of pulmonary imaging, which prepackages knowledge in a form that can be easily understood and readily visualized with high-quality representative images.
This book answers that need by providing the most important, relevant medical knowledge needed to handle pulmonary cases. It is divided into two sections, neoplastic disease and non-neoplastic disease. Chapters detail essential information about each disease, including presentation and the different modalities used to accurately diagnose and/or plan treatment. Major topics that are covered include bronchogenic carcinoma and other lung tumors, COPD, ILD, developmental lung disorders, pulmonary hypertension, and pulmonary infections. Each chapter includes extensive radiographic images to give a complete perspective on how these diseases present. Readers can easily see what the radiology of a particular disease entity looks like, what would be the differential diagnoses for a particular imaging abnormality, and compare the bullet review points associated with an image to their particular case.
This is an ideal guide for general and thoracic radiologists, pulmonary, sleep medicine, and critical care specialists, thoracic surgeons, as well as residents and all clinicians who treat patients with pulmonary disease.
Author(s): Subha Ghosh
Publisher: Springer
Year: 2021
Language: English
Pages: 247
City: Singapore
Preface
Contents
Part I: Neoplastic Disease
Chapter 1: Adenocarcinoma
Imaging Pearls (Figs. 1.1, 1.2, 1.3, 1.4, 1.5, and 1.6)
Suggested Reading
Chapter 2: Squamous Cell Carcinoma
Suggested Reading
Chapter 3: Large-Cell Carcinoma
Suggested Reading
Chapter 4: Adenosquamous Cell Carcioma
Suggested Reading
Chapter 5: Small-Cell Carcinoma
Suggested Reading
Chapter 6: Large-Cell Neuroendocrine Carcinoma
Suggested Reading
Chapter 7: Carcinoid Tumor
Atypical Carcinoid Tumor (Figs. 7.4 and 7.5)
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) (Fig. 7.6)
Suggested Reading
Chapter 8: Sarcomatoid Carcinoma
Carcinosarcoma (Fig. 8.1)
Pleuropulmonary Blastoma (Fig. 8.2)
Suggested Reading
Chapter 9: Salivary Gland–Type Tumors
Adenoid Cystic Carcinoma (Fig. 9.1)
Mucoepidermoid Carcinoma (Fig. 9.2)
Epithelial-Myoepithelial Tumor (Fig. 9.3)
Imaging Differential of Endoluminal Mass in the Airways
Suggested Reading
Chapter 10: Papillomatosis
Suggested Reading
Chapter 11: Adenomas
Sclerosing Pneumocytoma (Sclerosing Hemangioma) (Fig. 11.1)
Alveolar Adenoma (Fig. 11.2)
Suggested Reading
Chapter 12: Mesenchymal Tumors
Angiosarcoma (Fig. 12.1)
Epithelioid Hemangioendothelioma (Intravascular Sclerosing Bronchioloalveolar Tumor) (Figs. 12.2 and 12.3)
Kaposi Sarcoma (Figs. 12.4 and 12.5)
Pulmonary Artery Intimal Sarcoma (Figs. 12.6 and 12.7)
Schwannoma (Neurilemmoma) (Figs. 12.8, 12.9, and 12.10)
Pulmonary Hamartoma (Figs. 12.11 and 12.12)
Chondroma/Hamartoma (Figs. 12.13 and 12.14)
Lipoma (Figs. 12.15 and 12.16)
PEComatous Tumors: Lymphangioleiomyomatosis (LAM) (Fig. 12.17)
Inflammatory Pseudotumor (Fig. 12.18)
Suggested Reading
Chapter 13: Lymphohistiocytic Tumors
Extra-Nodal Marginal Zone Lymphoma of Mucosal Origin (MALT Lymphoma) (Fig. 13.1)
Lymphomatoid Granulomatosis (Fig. 13.2)
Diffuse Large B-Cell Lymphoma (Fig. 13.3)
Castleman Disease (Angiofollicular Lymphnode Hyperplasia/Giant Lymphnode Hyperplasia) (Figs. 13.4, 13.5, and 13.6)
Erdheim-Chester Disease (Fig. 13.7)
Suggested Reading
Chapter 14: Tumors of the Pleura
Malignant Pleural Mesothelioma (MPM) (Figs. 14.1 and 14.2)
Solitary Fibrous Tumor of the Pleura (Figs. 14.3, 14.4, and 14.5)
Suggested Reading
Part II: Non-neoplastic Disease
Chapter 15: Congenital Anomalies and Pediatric Lesions
Congenital Pulmonary Airway Malformation (CPAM)
Broncho-Pulmonary Sequestration
Bronchogenic Cyst
Swyer-James Syndrome (Swyer-Macleod-James Syndrome or Bret Syndrome)
Congenital Lobar Emphysema
Suggested Reading
Chapter 16: Chronic Obstructive Pulmonary Disease
Emphysema (Figs. 16.1, 16.2, 16.3, 16.4, and 16.5)
Bronchial Asthma/Chronic Bronchitis
Bronchiectasis
Cystic Fibrosis (Figs. 16.9 and 16.10)
Allergic Bronchopulmonary Aspergillosis (Figs. 16.11 and 16.12)
Rare Congenital Entities (Figs. 16.13 and 16.14)
Suggested Reading
Chapter 17: Small Airway Disease
Respiratory Bronchiolitis (Fig. 17.1)
Follicular Bronchiolitis (Fig. 17.2)
Obliterative Bronchiolitis/Bronchiolitis Obliterans Syndrome (Figs. 17.3, 17.4, and 17.5)
Suggested Reading
Chapter 18: Acute Lung Injury
Diffuse Alveolar Damage
Organizing Pneumonia
Acute Fibrinous and Organizing Pneumonia (AFOP) and Acute Eosinophilic Pneumonia (AEP)
Suggested Reading
Chapter 19: Idiopathic Interstitial Pneumonias
Revised ATS/ERS Classification of IIP: Multidisciplinary Approach
Usual Interstitial Pneumonia (UIP)/Idiopathic Pulmonary Fibrosis (IPF)
High-Resolution Computed Tomography Criteria for UIP Pattern (Figs. 19.1, 19.2, 19.3, and 19.4)
Nonspecific Interstitial Pneumonia (NSIP) (Fig. 19.5)
Respiratory Bronchiolitis – Interstitial Lung Disease (RBILD) Desquamative Interstitial Pneumonia (DIP) (Figs. 19.6 and 19.7)
Lymphoid Interstitial Pneumonia (LIP) (Fig. 19.8)
Pleuroparenchymal Fibroelastosis (Fig. 19.9)
Interstitial Pneumonia with Autoimmune Features (IPAF) (Fig. 19.10)
Suggested Reading
Chapter 20: Other Interstitial Lung Diseases
Hypersensitivity Pneumonitis (HP)
Sarcoidosis
Radiographic Stages of Sarcoidosis (Figs. 20.3, 20.4, 20.5, 20.6, 20.7, 20.8, and 20.9)
HRCT Features of Sarcoidosis
Pulmonary Langerhans Cell Histiocytosis (PLCH)
Relevant Imaging-Pathology Correlation (Figs. 20.10 and 20.11)
Eosinophilic Lung Disease
Simple Pulmonary Eosinophilia (Loeffler Syndrome)
Acute Eosinophilic Pneumonia
Chronic Eosinophilic Pneumonia
Idiopathic Hypereosionophilic Syndrome (Figs. 20.12, 20.13, and 20.14)
Pulmonary Alveolar Proteinosis (Fig. 20.15)
Suggested Reading
Chapter 21: Pneumoconiosis
Silicosis
Role of MRI and PET in Distinguishing PMF from Cancer (Figs. 21.1, 21.2, and 21.3)
Coal-Workers Pneumoconiosis (CWP) (Figs. 21.4 and 21.5)
Asbestos-Related Reactions (Figs. 21.6 and 21.7)
Berylliosis (Fig. 21.8)
Hard-Metal Pneumoconiosis and Hard-Metal Lung Disease (Figs. 21.9 and 21.10)
Talcosis (Figs. 21.11 and 21.12)
Suggested Reading
Chapter 22: Drug Reactions and Therapy Effects
Pulmonary Toxicity from Therapeutic Use (Fig. 22.1)
Amiodarone Toxicity (Fig. 22.2)
Lung Injury from Recreational Drug Abuse
Crack Lung (Fig. 22.3)
Heroin-Induced Acute Pulmonary Edema (Fig. 22.4)
Intravascular Talcosis (Fig. 22.5)
Injection Methylphenidate (Ritalin) (Fig. 22.6)
Suggested Reading
Chapter 23: Vasculitis and Other Causes of Pulmonary Hemorrhage
Diffuse Alveolar Hemorrhage (DAH) (Fig. 23.1)
ANCA Associated Pulmonary Vasculitis (Figs. 23.2, 23.3, 23.4, 23.5, 23.6)
Hypocomplementemic Urticarial Vasculitis (Anti-C1q Vasculitis) (Fig. 23.7)
Suggested Reading
Chapter 24: Pulmonary Hypertension
Chronic Thromboembolic Pulmonary Hypertension (Figs. 24.3 and 24.4)
Plexiform Pulmonary Hypertension (Fig. 24.5)
Pulmonary Veno-Occlusive Disease (PVOD) (Fig. 24.6)
Pulmonary Capillary Hemangiomatosis (PCH) (Fig. 24.7)
Intravascular Talcosis (Fig. 24.8)
Injection Methylphenidate (Ritalin) (Fig. 24.9)
Suggested Reading
Chapter 25: Bacterial Infections and Aspiration
Routes of Infection
Role of Computed Tomography in Lung Infections
Common Imaging Patterns of Pulmonary Infection with emphasis on Bacterial Infection
Increased Lung Attenuation Pattern (Airspace Consolidations and Ground-Glass Opacities) (Figs. 25.1, 25.2, and 25.3)
Nodular Pattern (Figs. 25.4, 25.5, 25.6, and 25.7)
Imaging of Complications (Figs. 25.8, 25.9, 25.10, and 25.11)
Imaging of Associated Abnormalities (Figs. 25.12 and 25.13)
Specific Pneumonias
Pseudomonas aeruginosa (Fig. 25.14)
Staphylococcus aureus (Fig. 25.15)
Actinomycosis (Figs. 25.16, 25.17, 25.18, and 25.19)
Nocardiosis
Malakoplakia – Rhodococcus
Aspiration Pneumonia (Figs. 25.22, 25.23, 25.24, and 25.25)
Suggested Reading
Chapter 26: Mycobacterial Infections
Mycobacterial Tuberculosis Infection of the Lungs
Non-tuberculous Mycobacterial Infection
Suggested Reading
Chapter 27: Fungal Infections
Histoplasmosis
Primary Histoplasmosis or Acute Pulmonary Histoplasmosis
Chronic Pulmonary Histoplasmosis
Progressive Disseminated Histoplasmosis
Fibrosing Mediastinitis
Coccidiodomycosis
Blastomycosis
Aspergillosis
Aspergilloma
Allergic Bronchopulmonary Aspergillosis
Semi-invasive Aspergillosis
Airway Invasive Aspergillosis
Angioinvasive Aspergillosis
Cryptococcosis
Mucormycosis
Pneumocystis pneumonia
Candidiasis
Suggested Reading
Chapter 28: Viral Infections
Selected Viruses Causing Respiratory Symptoms (Figs. 28.1, 28.2, 28.3, 28.4, 28.5, and 28.6)
Imaging Findings in COVID-19 (Figs. 28.7, 28.8, 28.9, 28.10, and 28.11)
Suggested Reading
Chapter 29: Parasitic Infections
Strongyloides (Figs. 29.1 and 29.2)
Dirofilariasis (Fig. 29.3)
Echinococcosis (Fig. 29.4)
Toxoplasmosis (Fig. 29.5)
Suggested Reading
Chapter 30: Miscellaneous, Mass-like, and Cystic Lesions
Nodular Lymphoid Hyperplasia (Fig. 30.1)
Amyloidosis (Figs. 30.2, 30.3, 30.4, 30.4, and 30.5)
Calcifications and Ossifications (Fig. 30.7)
Light-Chain Deposition Disease (Figs. 30.10 and 30.11)
IgG4-Related Lung Disease (Fig. 30.12)
Pulmonary Hyalinizing Granuloma (Fig. 30.13)
Emphysema with Placental Transmogrification and Lipomatous Change (Fig. 30.14)
Exogenous Lipoid Pneumonia (Fig. 30.15)
Benign Metastasizing Leiomyoma (Fig. 30.16)
Suggested Reading
Chapter 31: Lung Manifestations of Collagen Vascular Diseases
Rheumatoid Arthritis (Figs. 31.1, 31.2, 31.3, 31.4, and 31.5)
Scleroderma (Figs. 31.6 and 31.7)
Mixed Connective Tissue Disease (MCTD) (Fig. 31.8)
Dermatomyositis and Polymyositis (Fig. 31.9)
Systemic Lupus Erythematosus (Figs. 31.10, 31.11, 31.12, and 31.13)
Sjogren’s Syndrome (Figs. 31.14 and 31.15)
IPAF: Interstitial Pneumonitis with Autoimmune Features (Undifferentiated Connective Tissue Disease) (Fig. 31.16)
Suggested Reading
Chapter 32: Lung Involvement by Other Systemic Diseases
Birt-Hogg-Dubé Syndrome (Fig. 32.1)
Common Variable Immunodeficiency and Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) (Figs. 32.2 and 32.3)
Niemann-Pick Disease (Fig. 32.4)
Lung Manifestations of Inflammatory Bowel Disease (IBD) with emphasis on Necrobiotic Nodules (Figs. 32.5 and 32.6)
Suggested Reading
Index
